Nebenwirkungen · Micardis
Micardis 20 mg tablets Micardis 40 mg tablets Micardis 80 mg tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-089069 · Präparat HOS-083769
The overall incidence of adverse reactions reported with telmisartan was usually comparable to placebo (41,4% vs 43.9 %) in controlled trials in patients treated for hypertension. The incidence of adverse reactions was not dose related and showed no correlation with gender, age or race of the patients. The safety profile of telmisartan in patients treated for the reduction of cardiovascular morbidity was consistent with that obtained in hypertensive patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-17T14:21:00Z · SHA-256 0a398482ddd47534a4304565ae9e2ee9e7377ec0d61f91d44ea22c7544561f30 · Passage 4fc48c17dbbca4825f0877cd42a28719e8068ac83c2b82057f7628e1b4208858 · Zeichen 182–645 im Abschnitt